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1. INTRODUCTION
Primary sarcomas of the aorta are extremely un-
common. Depending on histomorphology and im-
munohistochemical pattern, intimal sarcomas can 
show angiosarcomatous differentiation; however, 
they more commonly correspond to high-grade 
malignant mesenchymal neoplasias, with variable 
myofibroblastic differentiation and, sometimes, other 
heterologous elements (for example, osteosarcoma)1. 
Fewer than 140 cases of aortic sarcoma have been 
described in the literature, and about 40 of those 
were classified as intimal sarcoma1–6. These tumours 
are found mostly in the abdominal aorta, and their 
clinical presentation depends on the precise site of 
occurrence2,3,7–9. A definitive diagnosis is often made 
only after surgery or even autopsy.
Here, we describe the case of a 60-year-old 
woman with a primary intimal sarcoma of the aortic 
arch, in whom signs of cerebral metastatic disease 
were the initial manifestation.
2. CASE DESCRIPTION
A 60-year-old white woman living on a houseboat 
in Kuala Lumpur, Malaysia, suddenly developed 
severe headaches, ataxia, and left-sided weakness. 
She had stopped smoking 5 years before presenta-
tion with those complaints; her husband remained a 
heavy smoker.
Magnetic resonance imaging showed several 
brain lesions throughout the right cerebral hemi-
sphere and cerebellum. Subsequent imaging by com-
bined positron-emission tomography and computed 
tomography (pet-ct) revealed a lytic lesion measuring 
2×1.5 cm in the right scapula, but no obvious primary 
tumour. Histologic assessment of a brain biopsy 
specimen revealed a malignant tumour composed 
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of large pleomorphic cells, which immunolabel-
ling showed to be positive for pan-cytokeratin and 
CD10, and negative for S-100, CDX2, synaptophysin, 
desmin, renal cell carcinoma antigen, and thyroid 
transcription factor 1. The proliferation index was 
60%–70%.
A dedifferentiated sarcomatoid carcinoma of 
lung, thyroid, or kidney was postulated, and the pa-
tient underwent palliative whole-brain radiotherapy, 
receiving a total dose of 30 Gy in 10 fractions.
Clinical examination after radiotherapy showed 
only a mild improvement in the patient’s neurologic 
symptoms. Another pet-ct scan detected fluorode-
oxyglucose (fdg)–positive lesions in the right palatine 
tonsil (diameter: 9 mm) and in several lymph nodes 
[to the right, behind the processus spinosus of the 
second vertebral body of the neck (diameter: 12 mm); 
to the left, at cervical level iii (diameter: 6 mm); to 
the right, retroclavicularly (6 mm); and mediastinal 
above the aorta (diameter: 11 mm)]. The right col-
lum scapulae, the middle third of the left clavicula, 
the left pubic bone, the colon descendens, and the 
sigmoid colon also showed fdg-positive osteolytic 
lesions. Further, the multiple lesions already known 
to be present in the right half of the brain were again 
detected, indicating at least partial nonresponse to 
radiotherapy [Figure 1(A)]. A biopsy of the tonsil 
showed no malignant cells.
The patient’s condition worsened again, with 
progressive dizziness and headache. Imaging of the 
brain by ct showed multiple lesions suggestive of 
metastases, with central necrosis and surrounding 
edema in the right hemisphere and cerebellum [Fig-
ure 1(B)]. Given the large number of brain metastases 
and the prior radiation, local treatment options were 
exhausted. High-dose steroids were started, and 
systemic treatment was initiated.
Because of the patient’s smoking history, the 
presence of brain and bone metastases, the fdg-
positive mediastinal and supradiaphragmatic lymph 
nodes, and the focal pan-cytokeratin positivity of the 
tumour, carcinoma of the lung was favoured as the 
primary tumour. Notably, no fdg-positive lesions 
were detected within the soft tissue or large vessels 
on pet-ct.
Chemotherapy with cisplatin and etoposide, 
accompanied by anti-edema treatment with dexa-
methasone and mannitol, was initiated. However, 
the patient’s general condition deteriorated rapidly, 
and she died within a few days.
At autopsy, an undifferentiated intimal sarcoma 
of the aortic arch, composed of cells similar to those 
seen in the brain metastases, was diagnosed. Tumour 
cells lined the intimal surface of the aortic lumen and 
infiltrated the media, causing a mural thrombus with 
thrombosis of the brachiocephalic artery and stenosis 
of the left carotid artery. The tumour cells could be 
found in both the mural thrombotic material and the 
intima and media of the aortic wall [Figure 2(B)]. 
Numerous metastases were seen in the right cerebrum 
and cerebellum, likely arising from tumour emboli 
originating at the truncus brachiocephalicus. A large 
serrated adenomatous polyp, without evidence of 
carcinoma or metastasis, was found in the colon. 
No lesions in the lung, kidneys, adrenal glands, or 
soft tissue were found. The tumour within the aorta 
was thus the only plausible primary tumour found at 
autopsy, its location providing an explanation for the 
metastases in the supradiaphragmatic lymph nodes, 
brain, and bones.
Microscopically, the brain metastases [Fig-
ure 2(A)] and the primary tumour in the aorta 
[Figure 2(C)] both consisted of large pleomorphic 
cells, with large pleomorphic nuclei and prominent 
nucleoli. Immunohistochemical analysis of the aortic 
tumour and brain metastases demonstrated diffuse 
positivity for vimentin and p53, and focal S-100 
staining. Tumour cells were negative for glial fibril-
lary acidic protein, Mdm2, CD31, CD34, desmin, 
pan-mela, thyroid transcription factor 1, and cyto-
keratins 7 and 20 [Figure 2(A–C)].
3. DISCUSSION
Aortic sarcomas are more common in men (2:1 
male-to-female ratio), and mean age at diagnosis is 
figure 1 Imaging of the patient. (A) Full-body combined positron-
emission tomography and computed tomography. (B) Brain com-
puted tomography.
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60 years (range: 48–85 years)10,11. Here, we report a 
case of primary intimal sarcoma of the aortic arch in 
a 60-year-old woman. In the literature, fewer than 40 
cases of this entity have been reported, and only about 
10% have been located in the aortic arch1,2,6. The most 
common location is the abdominal aorta (about 40%), 
followed by the thoracic aorta (about 20%), the thora-
coabdominal aorta (about 10%), and less commonly, 
the abdominal aorta and iliac or femoral artery (about 
5%)1. Clinical presentation depends on the tumour 
site. Most patients present with clinical symptoms 
attributable to embolic phenomena or vessel occlu-
sion or obstruction2,3,7–9,12,13. Rarely, presentations 
such as cerebral infarction, deep-vein thrombosis, 
gastrointestinal hemorrhage, and ulcerated ischemic 
bowel have been reported10,14,15.
At time of diagnosis, metastatic disease is present 
in about 75% of patients3,11, and metastases preferen-
tially occur in bone, lung, liver, spleen, kidney, and 
skin10,11. In our case, the patient initially presented 
with headache, ataxia, and hemiplegia because of 
numerous brain metastases. Although these clinical 
symptoms and metastases to brain are unusual, they 
can be explained by the localization of the primary 
tumour in the aortic arch.
The prognosis for patients with aortic sarcoma 
is poor because of the advanced stage at which the 
disease is diagnosed in most cases. Mean overall sur-
vival time is 16 ± 2.4 months (range: 0–168 months), 
and the 3- and 5-year survival rates are about 11.2% 
and 8% respectively2,10. Our patient died about 2 
months after presentation, an especially short sur-
vival time even for this type of disease.
The diagnosis of aortic sarcomas is challeng-
ing. Some studies suggest that magnetic resonance 
angiography with gadolinium is the most sensitive 
imaging method2,6,16,17. Magnetic resonance imaging 
might be of critical importance, because the tumour 
is often rather similar to an atherosclerotic plaque 
in ct imaging, and it is therefore often difficult to 
distinguish. Thus, to avoid a diagnostic delay when 
an aortic intimal sarcoma is suspected, magnetic 
resonance imaging might be the method of choice18.
Histologically, the diagnosis of intimal sarcoma 
is mostly a diagnosis of exclusion based on strict 
correlation with clinical presentation and imag-
ing, because this tumour has no specific pattern of 
diagnostic markers. In a high percentage of intimal 
sarcomas (70%–80%), overexpression of the Mdm2 
protein can be observed19,20; however, this finding is 
not specific, because many other tumours can also 
show this staining pattern.
Because of the low frequency of this disease, 
studies are currently unavailable, and therefore no 
standardized treatment protocols exist2. In the case of 
local disease without evidence of metastases, radical 
resection seems to represent the most effective thera-
peutic option. Chemotherapy or radiotherapy (or both) 
also appear promising for improving survival rates10,12. 
However, a large number of intimal sarcomas feature 
strong expression of platelet-derived growth factor 
receptor α (pdgfra) and of epidermal growth factor 
receptor, concurrent to pdgfra activation. Further, 
activated pdgfra and epidermal growth factor receptor 
frequently coexist with amplification and overexpres-
sion of the MDM2 oncogene. Therapies that target 
pdgfra, epidermal growth factor receptor, or Mdm2 
in intimal sarcomas therefore seem to be a reasonable 
approach to this rare tumour entity19.
figure 2 Histopathologic assessment of the patient’s lesions. 
(A) Brain metastasis. (B) Autopsy specimen, showing location of 
the analyzed sample from the primary tumour. (C) Primary tumour.
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4. SUMMARY
We report a challenging case of advanced intimal 
sarcoma of the aortic arch with numerous brain 
metastases and a single bone metastasis at initial 
presentation. Despite aggressive radiotherapy and 
chemotherapy, the patient died within a few weeks 
of presentation. This report clearly demonstrates 
the difficulties in diagnosing and treating this rare 
disease and the need for multicentre studies that 
will accrue more patients for investigations of 
optimal therapy.
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